标题
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
作者
关键词
-
出版物
LIVER INTERNATIONAL
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-08-22
DOI
10.1111/liv.14223
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Alpha fetoprotein (AFP) response and efficacy outcomes in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC).
- (2019) Robin Kate Kelley et al. JOURNAL OF CLINICAL ONCOLOGY
- Subsequent anticancer medication following first-line lenvatinib: A posthoc responder analysis from the phase 3 REFLECT study in unresectable hepatocellular carcinoma.
- (2019) Angel Alsina et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
- (2019) Michael Teufel et al. GASTROENTEROLOGY
- TGF-β1 Promotes Hepatocellular Carcinoma Invasion and Metastasis via ERK Pathway-Mediated FGFR4 Expression
- (2018) Jiawei Huang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome
- (2018) Alyson P Black et al. CURRENT OPINION IN PHARMACOLOGY
- Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
- (2018) Vincenzo Mazzaferro et al. GASTROENTEROLOGY
- Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
- (2018) Richard S. Finn et al. JOURNAL OF HEPATOLOGY
- The role of molecular enrichment on future therapies in hepatocellular carcinoma
- (2018) Jean-Charles Nault et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
- (2018) Lorenza Rimassa et al. LANCET ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis
- (2018) Linhua Zhou et al. International Journal of Surgery
- The immune contexture of hepatocellular carcinoma predicts clinical outcome
- (2018) Friedrich Foerster et al. Scientific Reports
- Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
- (2018) Xiaoping Wang et al. Canadian Journal of Gastroenterology and Hepatology
- Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma
- (2018) Masatoshi Kudo Liver Cancer
- Novel biomarkers in hepatocellular carcinoma
- (2018) Felice De Stefano et al. DIGESTIVE AND LIVER DISEASE
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
- (2018) Giorgia Marisi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The Role of Angiogenesis in Hepatocellular Carcinoma
- (2018) Michael A. Morse et al. CLINICAL CANCER RESEARCH
- Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
- (2018) Yasuo Tanaka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization
- (2017) Ahmed Gabr et al. EUROPEAN JOURNAL OF RADIOLOGY
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Structural basis for alpha fetoprotein-mediated inhibition of caspase-3 activity in hepatocellular carcinoma cells
- (2017) Bo Lin et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
- (2017) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
- (2017) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
- (2017) Andrea Notarpaolo et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- A Novel Prognostic Index in Patients With Hepatocellular Cancer Waiting for Liver Transplantation
- (2016) Quirino Lai et al. ANNALS OF SURGERY
- Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
- (2016) Sarah Berhane et al. Clinical Gastroenterology and Hepatology
- Advanced Hepatocellular Cancer: the Current State of Future Research
- (2016) Louise C. Connell et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study
- (2016) Gonzalo Sapisochin et al. HEPATOLOGY
- Alpha-fetoprotein and 18F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation
- (2016) Geun Hong et al. JOURNAL OF HEPATOLOGY
- Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America
- (2016) Federico Piñero et al. LIVER INTERNATIONAL
- The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization
- (2016) Lei Liu et al. Scientific Reports
- Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
- (2015) Christian Toso et al. HEPATOLOGY
- Prediction of risk for hepatocellular carcinoma by response of serum α-fetoprotein to entecavir therapy
- (2015) Sung Wook Yang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma
- (2015) Stephen L Chan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
- (2014) Thomas Yau et al. GASTROENTEROLOGY
- A New Laboratory-Based Algorithm to Predict Development of Hepatocellular Carcinoma in Patients With Hepatitis C and Cirrhosis
- (2014) Hashem B. El-Serag et al. GASTROENTEROLOGY
- Oral antiviral therapy improves the diagnostic accuracy of alpha-fetoprotein levels in patients with chronic hepatitis B
- (2014) Jae-Jun Shim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Silencing Alpha-Fetoprotein Inhibits VEGF and MMP-2/9 Production in Human Hepatocellular Carcinoma Cell
- (2014) Wenbo Meng et al. PLoS One
- A Peculiar Mutation Spectrum Emerging from Young Peruvian Patients with Hepatocellular Carcinoma
- (2014) Agnès Marchio et al. PLoS One
- Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment
- (2014) E. Horwitz et al. Cancer Discovery
- JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
- (2014) Masatoshi Kudo et al. Liver Cancer
- Are Biomarkers Still Helpful in Hepatocellular Carcinoma?
- (2013) Rolf Lamerz DIGESTION
- On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir
- (2013) Grace L.H. Wong et al. HEPATOLOGY
- A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
- (2013) Alessandro Vitale et al. JOURNAL OF HEPATOLOGY
- Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
- (2013) Lu He et al. MEDICAL ONCOLOGY
- Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: Long-term Results and Prognostic Factors in 162 Patients with Cirrhosis
- (2013) Dong Ho Lee et al. RADIOLOGY
- Alpha-fetoprotein: a renaissance
- (2013) A. A. Terentiev et al. TUMOR BIOLOGY
- Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
- (2012) A. G. Singal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
- (2012) Christophe Duvoux et al. GASTROENTEROLOGY
- FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma
- (2012) Tokuzo Arao et al. HEPATOLOGY
- Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma
- (2012) Nicola Personeni et al. JOURNAL OF HEPATOLOGY
- Epidemiology and Surveillance of Hepatocellular Carcinoma
- (2012) Do Young Kim et al. Liver Cancer
- Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C
- (2011) Richard K Sterling et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation
- (2011) Quirino Lai et al. CLINICAL TRANSPLANTATION
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
- (2011) Masatoshi Kudo et al. DIGESTIVE DISEASES
- The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma
- (2011) Shaheed Merani et al. JOURNAL OF HEPATOLOGY
- Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines
- (2011) Kenichi Takayasu et al. JOURNAL OF HEPATOLOGY
- HCC and angiogenesis: possible targets and future directions
- (2011) Andrew X. Zhu et al. Nature Reviews Clinical Oncology
- Zhx2 and Zbtb20: Novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer
- (2011) Martha L. Peterson et al. SEMINARS IN CANCER BIOLOGY
- MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma
- (2011) Kentaro Kojima et al. Nature Communications
- Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma
- (2010) Yu-Yun Shao et al. CANCER
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
- (2010) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- Favorable α-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation
- (2010) Ming-Chao Tsai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system
- (2010) Chia-Yang Hsu et al. JOURNAL OF HEPATOLOGY
- Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status
- (2010) Yun-feng Shan et al. MEDICAL ONCOLOGY
- Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor
- (2009) E. Vibert et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
- (2009) S J Schoenleber et al. BRITISH JOURNAL OF CANCER
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
- (2009) Jorge A. Marrero et al. GASTROENTEROLOGY
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
- (2009) Anna S. Lok et al. GASTROENTEROLOGY
- Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis
- (2009) Gisèle N'Kontchou et al. HEPATOLOGY
- A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma
- (2009) Bai-Hong Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ZHX2 is a repressor of α-fetoprotein expression in human hepatoma cell lines
- (2009) H. Shen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival
- (2009) Ahsun Riaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Liver Transplantation for Hepatocellular Carcinoma: Hangzhou Experiences
- (2009) Shu-Sen Zheng et al. TRANSPLANTATION
- Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria
- (2008) M. Ravaioli et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy
- (2008) Thomas Yau et al. CANCER
- EpCAM and -Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
- (2008) T. Yamashita et al. CANCER RESEARCH
- New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy
- (2008) Stephen L. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search